Liberal regulation for Covid-19 vaccine approval to improve access to jabs, says health secretary

By: |
April 14, 2021 3:50 AM

Union health secretary Rajesh Bhushan has said it was an enabling regulatory provision to enable those Covid-19 vaccines approved by credible foreign regulators to launch in the country and it denoted fastracking and streamlining of the regulatory approval system.

covid 19 vaccinationSix companies have tied up for manufacturing and technology for making the Sputnik vaccine in India.

Union health secretary Rajesh Bhushan has said it was an enabling regulatory provision to enable those Covid-19 vaccines approved by credible foreign regulators to launch in the country and it denoted fastracking and streamlining of the regulatory approval system. The availability of the vaccine becomes faster and it also opens up doors for import of bulk or finished vaccines in vials or import leading to fill and finish in India so it has a far reaching impact in the country, Bhushan said.

At present, Covaxin by Bharat Biotech and Covishield by Serum Institute of India have received Emergency Use Authorization (EUA) from the national regulator, Drugs Controller General of India (DCGI).  The regulator on Tuesday approved EUA for the Russian vaccine Sputnik and this was a significant step in the country’s vaccination drive.

Six companies have tied up for manufacturing and technology for making the Sputnik vaccine in India. The details regarding capacity, pricing, production and timeline for roll out in the national immunisation programme will get crystallised.

This decision will facilitate quicker access to foreign vaccines such as those of Moderna and Pfizer, but whether it would be applicable for the Serum Institute’s Novovax vaccines is not clear as it is currently undergoing trials in India. This decision was expected to encourage imports, including import of bulk drug material, optimal utilisation of domestic fill and finish capacity to provide a fillip to vaccine manufacturing capacity and total vaccine availability in the country.

Get live Stock Prices from BSE, NSE, US Market and latest NAV, portfolio of Mutual Funds, Check out latest IPO News, Best Performing IPOs, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.

Financial Express is now on Telegram. Click here to join our channel and stay updated with the latest Biz news and updates.

Next Stories
1NHPC carries out large-scale COVID-19 vaccination drive
2What organisations need to build a digitally enabled and talent-rich finance function
3Chola PAT soars 470% to Rs 243 cr